Showing results (11-20 of 462) with videos related to
Sort By:
Pageof 47
Arthritis Care & Research|November 7, 2022
Patient and Physician Global Assessments of Disease Status in Systemic SclerosisLaura Ross, Mandana Nikpour, Julie D'Aoust, et al.Rheumatology (Oxford, England)|December 6, 2018
Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortalityNicolas Richard, Marie Hudson, Mianbo Wang, et al.Arthritis & Rheumatology (Hoboken, N.J.)|June 27, 2024
Development and Initial Validation of the Novel Scleroderma Clinical Trials Consortium Activity IndexLaura Ross, Dylan Hansen, Susanna Proudman, et al.Arthritis Care & Research|February 28, 2022
Damage Trajectories in Systemic Sclerosis Using Group-Based Trajectory ModelingAriane Barbacki, Murray Baron, Mianbo Wang, et al.The Journal of Rheumatology|November 15, 2022
Evaluation of Patient and Physician Assessments of Gastrointestinal Disease Activity in Systemic SclerosisLaura Ross, Susanna Proudman, Jennifer Walker, et al.Current Opinion in Rheumatology|August 31, 2023
Composite measures to assess disease damage, disease severity and treatment response in systemic sclerosis clinical trialsLaura Ross, Mandana NikpourCurrent Opinion in Rheumatology|October 1, 2020
Cancer and scleroderma: recent insightsKathleen Morrisroe, Mandana NikpourEuropean Journal of Rheumatology|November 9, 2020
Screening for pulmonary arterial hypertension in systemic sclerosis: Now or never!Zoe R Brown, Mandana NikpourClinical and Experimental Rheumatology|June 15, 2021
Immunosuppression does not prevent severe gastrointestinal tract involvement in systemic sclerosisNicolas Richard, Geneviève Gyger, Sabrina Hoa, et al.Seminars in Arthritis and Rheumatism|January 12, 2021
Are troponin and B-type natriuretic peptides useful biomarkers for the diagnosis of systemic sclerosis heart involvement? A systematic literature reviewLaura Ross, Jayne Moxey, Mandana NikpourPageof 47